Original Research

Establishing a Genetic Cancer Risk Assessment Clinic

Author and Disclosure Information

 

References

Disclaimer
The opinions expressed herein are those of the author and do not necessarily reflect those of Federal Practitioner, Frontline Medical Communications Inc., the U.S. Government, or any of its agencies. This article may discuss unlabeled or investigational use of certain drugs. Please review the complete prescribing information for specific drugs or drug combinations—including indications, contraindications, warnings, and adverse effects—before administering pharmacologic therapy to patients.

Click here to read the digital edition.

Pages

Recommended Reading

Medication Adherence and Operating Room Efficiency for a Surgical Subspecialty
Federal Practitioner
Odontogenic Sinusitis
Federal Practitioner
One Hundred Case Series of Vocal Cord Dysfunction in a Military Treatment Facility
Federal Practitioner
Hearing Loss in People With Good Hearing
Federal Practitioner
Onetime, Nondrug Treatment May Be Better for Some MS Patients
Federal Practitioner
Dispensing and Monitoring Oral Anticancer Therapy
Federal Practitioner
The State of Hepatitis C Care in the VA
Federal Practitioner
Focus on Reducing the Discomfort, Not the Fever
Federal Practitioner
Write for Us, Right for You
Federal Practitioner
March 2017 Digital Edition
Federal Practitioner